Paid Clinical Trials in Jersey City, NJ
As of August 2026, 40 paid clinical trials are recruiting in Jersey City, New Jersey. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Jersey City offers studies at sites including Jersey City Medical Center for conditions such as Acute Myocardial Infarction, Anatomic Stage II Breast Cancer AJCC v8, Coronary Artery Disease, Muscle Invasive Bladder Urothelial Carcinoma. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Jersey City
Trials by drug in Jersey City
Filter results
38 clinical trials
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Combination in Participants 12 Years and Older With Asthma
SuperSaturated Oxygen Comprehensive Observational Registry
Safety, Efficacy, & Use of ViviGen Cellular Bone Matrix Allograft in Orthopaedic Fracture Care
A Prospective, Multicenter, Randomized Controlled Trial to Investigate the Value of Coronary CT Angiography in the Understanding and Management of Coronary Calcium (The Optimal Trial)
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab
Testing the Addition of Chemotherapy or Chemo-Immunotherapy to the Usual Surgery for Advanced Head and Neck Cancer
Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer
Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Maintenance Compared to Standard Chemoradiation With Pembrolizumab Followed by Pembrolizumab Maintenance in High-Risk Cervical Cancer
Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer
Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Removal of the Bladder, Kidney, Ureter, and Urethra for Urothelial Cancer Treatment, MODERN Study
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab
Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial
Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer
Testing the Use of Neratinib or the Combination of Neratinib and Palbociclib Targeted Treatment for HER2+ Solid Tumors (A ComboMATCH Treatment Trial)
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Testing the Addition of an Anti-Cancer Drug, TRC102, to the Usual Chemotherapy Treatment (Pemetrexed, Cisplatin or Carboplatin) During Radiation Therapy for Stage III Non-Squamous Non-Small Cell Lung Cancer
ATATcH Alternating Treatment Plans for Advanced Cancer
IMPRoving Outcomes in Vascular DisEase - Aortic Dissection
Targeted Genomic Analysis of Blood and Tissue Samples From Patients With Cancer
DPYD Pharmacogenomics and Fluoropyrimidine (FP) Dose-Adjustment
Statins for Reduction of Cardiac Toxicity in Patients Receiving HER2 Targeted
Physiology-guided vs Angiography-guided Non-culprit Lesion Complete Revascularization for Acute MI & Multivessel Disease
Periprosthetic Fracture Registry (PPFx)
Sequential TAS-OX Alternating With TAS-IRI Plus Bevacizumab for Late-Line Metastatic Colorectal Cancer
ACP Video Intervention for Patients With Life-Limiting Illness
A Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa Injection in Participants With Known or Suspected F2- or F3-stage MASH
A Phase 2 Study of MZE829 in Adults With APOL1 Kidney Disease
A Study to Evaluate AZD7760 Safety and Pharmacokinetics in Healthy Adults (Phase I) and Adults With End-stage Kidney Disease on Hemodialysis With a Central Venous Catheter (Phase IIa)
Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function
Top Research Study Locations in Jersey City
Researchers run research studies in Jersey City, NJ at 18 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Jersey City Medical Center | Anatomic Stage II Breast Cancer AJCC v8, Muscle Invasive Bladder Urothelial Carcinoma, Ovarian Carcinoma | 21 |
| RWJBarnabas Health Jersey City Medical Center | Breast Neoplasms, Colon Cancer, Colorectal Neoplasms | 2 |
| Amb Pain and Disability Mgmt Ctr | Lumbar Spinal Stenosis | 1 |
| Clover Health | End Stage Disease, Health Care Utilization | 1 |
| GSK Investigational Site | Non-alcoholic Fatty Liver Disease | 1 |
| Garden State Advanced Medical Group | Acute Myocardial Infarction | 1 |
| HACKENSACK MERIDIAN HEALTH, Inc | Arterial Occlusive Diseases, Arteriosclerosis, Cardiovascular Diseases | 1 |
| Jersey City Medical Center RWJ Barnabas Health | Periprosthetic Fracture Around Prosthetic Joint Implant, Periprosthetic Fractures | 1 |
| New Jersey Kidney Care | End Stage Kidney Disease | 1 |
| RWJ Barnabas Health | Acute Myocardial Infarction, Coronary Artery Disease | 1 |
| RWJ- Jersey City Medical Center | AMI, STEMI - ST Elevation Myocardial Infarction | 1 |
| RWJBarnabas Health | Fracture Arm, Fracture of Femur, Fracture, Tibial | 1 |
| RWJBarnabas Health - - Jersey City Medical Medical | Cardiac Toxicity, Early-stage Breast Cancer | 1 |
| RWJBarnabas Health - Jersey City | Head and Neck Cancer, Lung Cancer | 1 |
| RWJBarnabas Health - Jersey City Medical Center, Jersey City | Malignant Neoplasm | 1 |
| Rutgers UH Vascular Center | Type B Aortic Dissection | 1 |
| SurgiCore Jersey City | Lumbar Spinal Stenosis | 1 |
| Teva Investigational | Asthma | 1 |
Active & Upcoming Studies in Jersey City (2026)
Recruiting trials in Jersey City grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (20 active studies)
- Testing the Addition of Chemotherapy or Chemo-Immunotherapy to the Usual Surgery for Advanced Head and Neck Cancer · Phase 2 · National Cancer Institute (NCI)
- Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial · Phase 2 · National Cancer Institute (NCI)
Cardiovascular (5 active studies)
- A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity · Phase 3 · Novo Nordisk A/S
- A Prospective, Multicenter, Randomized Controlled Trial to Investigate the Value of Coronary CT Angiography in the Understanding and Management of Coronary Calcium (The Optimal Trial) · Fundación EPIC
Diabetes & metabolic (2 active studies)
- A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity · Phase 3 · Novo Nordisk A/S
- A Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa Injection in Participants With Known or Suspected F2- or F3-stage MASH · Phase 3 · GlaxoSmithKline
Common conditions studied in Jersey City
- Acute Myocardial Infarction (2 active studies)
- Anatomic Stage II Breast Cancer AJCC v8 (2 active studies)
- Coronary Artery Disease (2 active studies)
- Muscle Invasive Bladder Urothelial Carcinoma (2 active studies)
- Ovarian Carcinoma (2 active studies)
- Stage III Laryngeal Cancer AJCC v8 (2 active studies)
Leading research sponsors in Jersey City
- National Cancer Institute (NCI)
- NRG Oncology
- Rutgers, The State University of New Jersey
- AstraZeneca
- AO Innovation Translation Center
Frequently asked questions
How many paid clinical trials are currently recruiting in Jersey City?
There are approximately 40 recruiting clinical trials in Jersey City, New Jersey listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Jersey City pay participants?
Most recruiting trials in Jersey City compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Jersey City?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Jersey City?
The most common conditions under active study in Jersey City include Acute Myocardial Infarction (2), Anatomic Stage II Breast Cancer AJCC v8 (2), Coronary Artery Disease (2), Muscle Invasive Bladder Urothelial Carcinoma (2), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Jersey City?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Jersey City on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Jersey City?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Jersey City?
Recruiting research sites in Jersey City include Jersey City Medical Center, RWJBarnabas Health Jersey City Medical Center, Amb Pain and Disability Mgmt Ctr, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Jersey City right now?
The largest active categories in Jersey City are Cancer & tumors (20), Cardiovascular (5), Diabetes & metabolic (2). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.